Skip to main content
Show — Main navigation Hide — Main navigation
  • Home
  • About
    • The Chair
    • Inquiry Team
    • Expert Groups
    • Inquiry Intermediaries
    • Core Participants
    • Legal Representatives
    • Financial Reports
  • Approach
    • Terms of reference
    • List of Issues
    • Statements of approach
    • Inquiry Principles
  • News
    • News
    • Newsletter Archive
  • Reports
    • Compensation Framework Study
    • First Interim Report
    • Second Interim Report
    • The Inquiry Report
  • Evidence
    • Evidence
    • Hearings Archive
  • Compensation
  • Support
    • NHS Psychological Support
    • Confidential Psychological Support
    • Support Groups
    • Infected Blood Support Schemes
    • Treatment and aftercare
    • Medical Evidence
    • Expenses Guidance
  • Contact us
Accessibility Tool
  • Zoom in
  • Zoom out
  • Reset
  • Contrast
  • Accessibility tool
Get in touch

Quick Exit

Subscribe to Search results

The New England Journal of Medicine published an article by Durack titled "Opportunistic infections and Kaposi's sarcoma in homosexual men".

Published on: 27 August, 2024

Strategy caucuses of the plasma collection and manufacturing interests in advance of their meeting regulators, the CDC and others were to become a common occurrence.

Published on: 27 August, 2024

Dr Ojala's (Cutter) memo of a meeting on non-specific (surrogate) testing concluded: "In summary, the conclusion of this meeting was that the time had come for Hepatitis core anti-body testing for plasma. Implementation will probably be achieved during 1984 for the industry."

Published on: 27 August, 2024

Dr Ojala's (Cutter) memo of a meeting on non-specific (surrogate) testing stated: "The approval of our heat-treat submission, in conjunction with core-screened plasma could present us with a potent marketing advantage. We made no mention of our plans to the others."

Published on: 27 August, 2024

The New England Journal of Medicine published an article by Siegal et al titled "Severe Acquired Immunodeficiency in Male Homosexuals, Manifested by Chronic Perianal Ulcerative Herpes Simplex Lesions".

Published on: 18 October, 2024

Inquiry publishes financial report

Published on: 28 August, 2024

Rhys Brennan

Published on: 25 February, 2025

At an Association of Haematologists North East Thames Region Working Party in Haemophilia meeting, Dr Lane "projected utilisation of factor VIII concentrate to grow to 60M iu [international units] per annum over a ten-year period" but suggested "100M iu per annum" as a more realistic estimate to achieve self-sufficiency.

Published on: 17 October, 2024

It was apparent that the fractionation capacity in England would need significant expansion.

Published on: 30 August, 2024

A Working Party on Human Antihaemophilic Globulin meeting determined "As the HAHG [human antihaemophilic globulin] concentrate prepared from plasma pools of up to 30-40 litres in volume apparently carried a risk of transmitting serum hepatitis, it was considered inadvisable...to increase the plasma pool volume much above this size".

Published on: 17 October, 2024

There was an upward shift in estimates of future needs, though slighter on this occasion. Current demand for Factor 8 was probably in the region of 60 million international units but, if clinical freedom continued, it could reach 100 million international units per annum.

Published on: 30 August, 2024

Alec Parrott wrote a letter to Susan Maunsell proposing a solution to the problem of securing an agreement acceptable to the workforce if asked to run a 24- hour shift system.

Published on: 30 August, 2024

Dr Maycock published "Present Sources of Materials for Treatment of Haemophilia and Potential Future Sources" showing the limits of fractionation capacity contributing to blood product shortfall; in order to meet the preferred number of units of cryoprecipitate and factor concentrates, capacity would have to increase by 800L a week.

Published on: 30 August, 2024

An editorial in The British Medical Journal entitled "Blood Donors and the Transfusion Service" argued that the blood services were ill-equipped to do the job as a modern transfusion service, suggesting that the "shortage" of blood and therefore plasma, allowing entry to the UK of the products of pharmaceutical companies, was not a real shortage, but a consequence of poor administration, organisation and underfunding.

Published on: 30 August, 2024

Andrew Mitchell wrote a letter to Malcolm Widdup noting the SHHD's proposal that the new blood products unit "should operate on the continuous flow principle and should be designed to a workload of 1,500 litres of plasma per week; but it will be capable of adaptation, without substantial structural alterations, to operate at levels up to 3,000 litres per week should this become necessary".

Published on: 30 August, 2024

The discussion in the Expert Group on the Treatment of Haemophilia - in particular its belief that "with the extension of home treatment joint surgery etc the current target may represent no more than _ to _ of the amount of Factor VIII which may be required in 5 years time or less" - was reported to the Central Committee of the National Blood Transfusion Service.

Published on: 30 August, 2024

The special allocations appear to have become subsumed as a part of the standard regional allocations, revised "in the usual way" to take account of cost increases.

Published on: 30 August, 2024

The Expert Report to the Infected Blood Inquiry: Public Health and Administration was produced, providing some evidence of the constrained financial position of the UK during the 1970s.

Published on: 30 August, 2024

A booklet entitled "Notes on Transfusion" was issued by the DHSS, SHHD and the Welsh Office.

Published on: 30 August, 2024

Dr Owen authorised the allocation of special finance to assist the National Health Service in becoming self-sufficient as soon as practicable.

Published on: 30 August, 2024

Pagination

  • First page First
  • Previous page Previous
  • …
  • Page 2136
  • Page 2137
  • Page 2138
  • Page 2139
  • Current page 2140
  • Page 2141
  • Page 2142
  • Page 2143
  • Page 2144
  • …
  • Next page Next
  • Last page Last

Inquiry

  • Home
  • About
  • Approach
  • Participate
  • News
  • Evidence
  • Support
  • Get in touch

Legal

  • Terms & Conditions
  • Cookies notice
  • Privacy Notice
  • Accessibility tool

Address

Infected Blood Inquiry
5th Floor
Aldwych House
71-91 Aldwych
London
WC2B 4HN
 
Images of individuals on the website are used with the agreement of those featured or are stock images.

Follow us

© Crown copyright. Licensed under the Open Government Licence v3.0 except where otherwise stated.